Sign inJoin waitlistJoin the waitlist

DM

David Minor

Physician · SAN FRANCISCO ONCOLOGY ASSOC

Credentials: ·

History

SAN FRANCISCO ONCOLOGY ASSOC
Present

Medical Oncology
Internal Medicine

Research

Nivolumab and ipilimumab versus ipilimumab in untreated melanoma
New England Journal of Medicine · 2015 · 2,283 citations
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
The Lancet Oncology · 2015 · 2,197 citations
Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2…
The Lancet Oncology · 2016 · 772 citations

Mohammed Kashani-Sabet
12 papers
Omid Hamid
7 papers
KK
Kevin Kim
6 papers
JW
Jeffrey Weber
5 papers
Stanley Leong
5 papers
Stephen Hodi
5 papers
Gerald Linette
4 papers
KG
Kenneth Grossmann
4 papers
SO
Steven O'Day
4 papers
AT
Ahmad Tarhini
3 papers
Asim Amin
3 papers
David Berman
3 papers